Brief: Protara Therapeutics Reports Q4 Loss Of 91 Cents Per Share
09/03/2022 12:31
March 9 (Reuters) - Protara Therapeutics Inc TARA.O :
* Q4 LOSS PER SHARE $0.91
* STRONG CASH POSITION OF $130.7M AS OF DECEMBER 31, 2021 EXPECTED TO FUND
OPERATIONS INTO MID-2024
Source text for Eikon: ID:nGNX3ZZwTJ
Further company coverage: TARA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Protara Therapeutics
See all newsProtara Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Protara Therapeutics Q2 net loss widens on higher expenses
Brief: Protara Therapeutics - Enters Sales Agreement With TD Cowen For Common Stock Offering
Brief: Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses
Protara Therapeutics Q1 net loss widens on higher expenses